| Literature DB >> 36123060 |
Victoria I Barbeau1, Leen Madani2, Abdulah Al Ameer2, Elizabeth Tanjong Ghogomu2, Deirdre Beecher3, Monserrat Conde4,5, Tracey E Howe6, Sue Marcus7, Richard Morley8, Mona Nasser9, Maureen Smith10, Jo Thompson Coon11, Vivian A Welch2.
Abstract
OBJECTIVE: To explore and map the findings of prior research priority-setting initiatives related to improving the health and well-being of older adults.Entities:
Keywords: Dementia; EPIDEMIOLOGY; GERIATRIC MEDICINE; PUBLIC HEALTH
Mesh:
Year: 2022 PMID: 36123060 PMCID: PMC9486333 DOI: 10.1136/bmjopen-2022-063485
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Flow diagram of the study selection following the PRISMA template. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Methods, participants and funding sources of the included studies (n=64)
| Category | Subcategory | N (%) |
| Method/s used to collect initial priorities | Survey (only) | 21 (33) |
| Consultation (only)* | 18 (28) | |
| Evidence (only) | 2 (3) | |
| Mixed methods† | 23 (36) | |
| Method/s used to prioritise priorities | Consensus (only)‡ | 24 (38) |
| Survey (only) | 20 (31) | |
| Survey and consensus | 16 (25) | |
| Not described | 4 (6) | |
| Framework | JLA | 12 (19) |
| Delphi | 11 (17) | |
| Nominal group | 9 (14) | |
| CITRA | 5 (8) | |
| World Café | 2 (3) | |
| No established framework used | 25 (39) | |
| Geographical location of participants | USA | 22 (34) |
| UK | 13 (20) | |
| Canada | 9 (14) | |
| Europe§ | 6 (11) | |
| Australia | 1 (2) | |
| Japan | 1 (2) | |
| Multiple continents | 9 (14) | |
| Not specified | 2 (3) | |
| Participant types | Clinicians | 56 (88) |
| Older adults | 35 (55) | |
| Caregivers | 24 (38) | |
| Personal support workers | 17 (27) | |
| Range of stakeholders¶ | 49 (77) | |
| Funding | Government | 13 (20) |
| University/Institute | 10 (16) | |
| Not for profit | 5 (8) | |
| Professional association | 2 (3) | |
| Industry | 1 (2) | |
| Multiple | 18 (28) | |
| No funding | 3 (5) | |
| Not reported | 12 (19) |
*Consultation methods were classified as methods involving collecting research priorities through face-to-face interactions with key stakeholder groups and could have included interviews, workshops, expert panels and focus groups.
†Study design involved multiple methods (eg, survey and consensus).
‡Consensus methods were classified as methods involving prioritisations through face-to-face group discussion between key stakeholder groups and could have included workshops, expert panels and focus groups.
§The European priority settings involved participants from Austria, Belgium, Bosnia Herzegovina, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Iceland, Ireland, Italy, The Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland and Turkey.
¶Range of stakeholders: 2+ types of stakeholders from the following list: clinicians, patients, caregivers, government, industry, researchers, educators, managers, administrators and funding agencies.
JLA, James Lind Alliance; CITRA, Cornell Institute for Translational Research on Ageing Model.
Percentages of full-text studies that meet each of the REPRISE criteria
| Category | REPRISE criteria | Percentage of studies (n=51) |
| Context and scope | 1.Geographical scope defined | 65 |
| 2.Health area, field, focus described | 100 | |
| 3.Intended beneficiaries defined | 100 | |
| 4.Target audience of the priorities defined | 98 | |
| 5.Research area was stated | 100 | |
| 6.Type of research questions described | 100 | |
| 7.Time frame defined | 2 | |
| Governance and team | 8.Selection and structure of the leadership and management team described | 47 |
| 9.Characteristics of the team described | 39 | |
| 10.Training or experience relevant to conducting priority setting described | 28 | |
| Framework for priority setting | 11.Was an established framework used | 63 |
| Stakeholders or participants | 12.Inclusion criteria for stakeholders involved in priority-setting defined | 94 |
| 13.Strategy or method for identifying and engaging stakeholders reported | 78 | |
| 14.No of participants and/or organisations involved indicated | 90 | |
| 15.Characteristics of stakeholders described | 98 | |
| 16.Stated if reimbursement for participation was provided | 4 | |
| Identification and collection of research priorities | 17.Methods for collecting initial priorities described | 100 |
| 18.Methods for collating and categorising priorities described | 86 | |
| 19.Methods and reasons for modifying (removing, adding, reframing) priorities described | 69 | |
| 20.Methods for refining or translating priorities into research topics or questions | 71 | |
| 21.Methods for checking whether research questions or topics have been answered | 29 | |
| 22.No of research questions or topics reported at each stage of the process | 90 | |
| Prioritisation of research questions or topics | 23.Methods for prioritising research topics or questions reported | 98 |
| 24.Method or threshold for excluding research topics/questions stated | 71 | |
| Output | 25.Approach to formulating the research priorities stated | 77 |
| Evaluation and feedback | 26.How the process of prioritisation was evaluated described | 16 |
| 27.How priorities were fed back to stakeholders and/or to the public; and how feedback (if received) was addressed and integrated was described | 28 | |
| Implementation | 28.Strategy or action plans for implementing priorities described | 41 |
| 29.Plans, strategies or suggestions to evaluate impact described | 39 | |
| Funding and conflict of interest | 30.Sources of funding declared | 96 |
| 31.Conflicts or competing interests declared | 82 |
Colours are used for clarity (0%–33% red, 34%–66% amber and 67%–100% green).
REPRISE, Reporting Guideline for Priority Setting of Health Research.
Characteristics of the PICO priorities (n=217)
| Category | Subcategory | N (%) |
| Condition* | Ischaemic heart disease | 10 (5) |
| Stroke | 2 (1) | |
| COPD | 0 | |
| Alzheimer’s diseases and other dementias | 24 (11) | |
| Diabetes mellitus type 2 | 5 (2) | |
| Tracheal, bronchus and lung cancer | 10 (5) | |
| Low back pain | 3 (1) | |
| Lower respiratory infections | 0 | |
| Age-related hearing loss | 1 (1) | |
| Falls | 16 (7) | |
| Other† | 71 (29) | |
| No condition specified | 75 (33) | |
| Outcomes | Social/psychosocial | 74 (34) |
| Medical/clinical | 165 (76) | |
| Caregiver focused | 51 (24) |
*The top 10 causes of burden of disease are displayed in the order of prevalence in older adults globally, as reported by WHO.
†Conditions of focus that are not captured by the top 10 list of burden diseases (eg, frailty, delirium, gout and visual impairment).
COPD, chronic obstructive pulmonary disease; PICO, population–intervention–control–outcome.
Figure 2Matrix of PICO priorities as classified by their associated ICHI interventions and who healthy ageing framework ICF outcomes. The size of the circles corresponds to the number of priorities (n=217). ICF, International Classification of Functioning; ICHI, International Classification of Health Interventions; PICO, population–intervention–control–outcome.
Types of the broad research topics
| Category | N (%) | ||
| No older adults* | Older adults | All broad topics | |
| Health services and systems | 35 (23) | 25 (21) | 60 (22) |
| Epidemiology and aetiology | 33 (22) | 8 (7) | 41 (15) |
| Treatment | 21 (14) | 17 (14) | 38 (14) |
| Screening, diagnosis, and assessment | 11 (7) | 22 (18) | 33 (12) |
| Caregiver needs and support | 20 (13) | 1 (1) | 21 (8) |
| Natural history, prognosis, and outcomes | 7 (5) | 14 (12) | 21 (8) |
| Digital technologies | 3 (2) | 15 (12) | 18 (7) |
| Outcome measurement | 5 (3) | 4 (3) | 9 (3) |
| Patient and caregiver perspectives | 5 (3) | 3 (2) | 8 (3) |
| Research capacity build | 3 (2) | 5 (4) | 8 (3) |
| Economic evaluation | 4 (2) | 1 (1) | 5 (2) |
| Social services and systems | 3 (2) | 2 (2) | 5 (2) |
| Prevention | 1 (1) | 4 (3) | 5 (2) |
*Topics gathered from priority-setting initiatives that did not include older adults.